VFF Village Farms International, Inc.
Price Chart
Executive Summary
Village Farms reported Q1 2026 results with consolidated net sales of $50.2M (+27% YoY) and GAAP net income of $2.9M ($0.03 basic EPS), compared to a net loss of $6.7M in Q1 2025. International export cannabis sales surged 171% YoY to a record $14.6M, and Adjusted EBITDA from continuing operations grew 118% to $9.9M. The company maintained a top-5 Canadian market share and held the #1 position in dried flower, while capacity expansions in Canada and the Netherlands are expected to drive stronger sales in 2H 2026.
Key Financial Metrics
Actionable Insight
Strong Q1 beat with accelerating international export growth and margin expansion validates the thesis of profitable scaling. The $15M tax payment and $9.2M capex consumed cash, but management expects cash balance to grow from operations through year-end. Watch for Q2 2026 results to confirm sequential international export growth and initial contributions from Delta 2 expansion. The Trump executive order on cannabis rescheduling (hearing June 29) adds a potential catalyst for U.S. cannabis exposure.
Key Facts
- Consolidated net sales increased 27% YoY to $50.2M from $39.7M
- GAAP net income attributable to shareholders of $2.9M ($0.03 basic EPS) vs. net loss of $6.7M ($0.06 loss per share) in Q1 2025
- International export cannabis sales grew 171% YoY to a record $14.6M
- Adjusted EBITDA from continuing operations increased 118% to $9.9M (20% of sales) from $4.5M (11.5% of sales)
- Cannabis segment gross margin improved to 43% from 39% YoY, above the high end of the 30-40% target range for the fourth consecutive quarter
- Cash and cash equivalents stood at $50.5M at March 31, 2026, down from $81.2M at year-end 2025 due to $15M in income tax payments, $9.2M in capex, and $6.4M in share repurchases
- Company expects to grow cash balance from operating cash flow through year-end
- Delta 2 expansion in Canada expected to add 40 tonnes of annualized capacity (~33% increase) once fully completed in 2027
- Netherlands Phase II facility expected to quintuple total production to ~10 tonnes annually, ramping to full capacity by end of 2026
- Favorably amended Farm Credit Canada loan: 50bps rate reduction and maturity extended to February 2031
Financial Impact
Revenue growth of 27% YoY to $50.2M; GAAP EPS of $0.03 vs. consensus estimate of $0.02 (beat); Adjusted EBITDA up 118% to $9.9M
Risk Factors
- Cash burn in Q1 ($30.7M decrease in cash) driven by tax payments, capex, and buybacks; liquidity needs monitoring if operating cash flow doesn't recover as expected
- Capacity expansions in Canada and Netherlands may face delays or cost overruns
- Canadian cannabis market remains competitive; market share could erode
- U.S. cannabis rescheduling is uncertain and subject to administrative and legal challenges
- Foreign exchange exposure (CAD/USD) could impact reported results
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-215669 |
| Document: vff-20260511.htm | 0001193125-26-215669 |
| Document: 0001193125-26-215669-index-headers.html | 0001193125-26-215669 |
| Document: 0001193125-26-215669-index.html | 0001193125-26-215669 |
| Document: 0001193125-26-215669.txt | 0001193125-26-215669 |
| 8-K Data (Synthetic) | 0001193125-26-215669 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
1d ago
|
Institutional Cluster
| $2.08 awaiting T+1 | awaiting T+1 | — | $2.03 (−2.40%) |
|
Jun 8, 2026
5d ago
|
8-K
| $2.08 awaiting T+1 | awaiting T+1 | — | $2.03 (+2.40%) |
|
Jun 5, 2026
7d ago
|
424B5
| $2.08 awaiting T+1 | awaiting T+1 | — | $2.03 (+2.40%) |
|
Jun 5, 2026
8d ago
|
8-K
| $2.47 awaiting T+1 | awaiting T+1 | — | $2.03 (+17.81%) |
|
Jun 2, 2026
10d ago
|
8-K
| $2.40 $2.47 | ▲ +2.92% | ▲ +2.52% | $2.03 (−15.42%) |
|
May 11, 2026
4w ago
|
8-K
| $2.64 $2.67 | ▲ +1.14% | ▲ +1.27% | $2.03 (−23.11%) |
|
May 11, 2026
4w ago
|
Press Release
| $2.64 $2.67 | ▲ +1.14% | ▲ +1.27% | $2.03 (−23.11%) |
|
Apr 3, 2026
10w ago
|
8-K
| $2.72 $2.67 | ▼ −1.84% | ▼ −1.90% | $2.03 (−25.37%) |
|
Mar 12, 2026
13w ago
|
8-K
| $3.05 $2.87 | ▼ −5.90% | ▼ −5.30% | $2.03 (−33.44%) |
|
Mar 12, 2026
13w ago
|
Press Release
| $3.05 $2.87 | ▼ −5.90% | ▼ −5.30% | $2.03 (−33.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access